# Perioperative Nicotine for Postoperative Pain and Nausea: A Systematic Review with Clinical and Methodological Insights

**Authors:** Feras Twfeq Almogbel, Mohammed Ali Alghamdi, Ali Mohamed Elkarouri, Abdulrahman Fahad Alharbi, Layan Saud Almutairy, Lama Zaid Alzimami, Atheer Alkhalil Medkhali, Reem Abduldaem Aloufi, Shatha Muways Alotaibi, Rawan Fauzy Allehyani, Jawaher Hani Alabdualqader, Mona Jalal Awaji

PMC · DOI: 10.5812/aapm-164878 · Anesthesiology and Pain Medicine · 2025-11-21

## TL;DR

This review examines if nicotine given before or during surgery helps reduce postoperative pain and nausea, but finds inconsistent results due to differences in study methods.

## Contribution

A systematic review and narrative synthesis of nicotine's effects on postoperative pain and nausea, highlighting clinical and methodological variability.

## Key findings

- Perioperative nicotine reduced postoperative pain and opioid use in some studies.
- Nicotine's effect on postoperative nausea and vomiting was inconsistent.
- Variability in dosage and patient populations complicates clinical recommendations.

## Abstract

Nicotine has been investigated in prior studies for its analgesic effects and its impact on postoperative nausea and vomiting (PONV), yet results have been inconsistent.

This systematic review and narrative synthesis evaluates the effects of perioperative nicotine administration on postoperative pain control and PONV in patients undergoing general anesthesia.

A systematic literature review was conducted, and findings were summarized narratively. Comprehensive searches were performed in PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar for studies published between 2004 and 2023, using a PICO-based approach. The PICO criteria included: Patients undergoing general anesthesia, perioperative nicotine as the intervention, placebo or no nicotine as the comparator, and pain scores as the primary outcome. The Mendeley application was utilized to eliminate duplicate data. Title, abstract, and full-text screenings were independently conducted by all authors using the online review platform Rayyan. Final data were individually extracted into Excel spreadsheets. The risk of bias in the included studies was assessed with the Cochrane Risk of Bias 2 (RoB 2) tool.

Eleven studies encompassing 753 participants (384 receiving nicotine, 369 controls) were included. Of these, 514 were female and 239 were male, all having undergone different surgical procedures and receiving nicotine via various methods and dosage forms. The majority of participants were nonsmokers. Primary outcomes across the studies predominantly involved postoperative pain scores, while secondary outcomes included the incidence of PONV, antiemetic requirements, and opioid consumption. No additional analyses were performed due to heterogeneity among the included studies.

Although perioperative nicotine administration demonstrated reductions in postoperative pain, nausea, vomiting, and opioid consumption in some studies, the effect of nicotine on PONV was inconsistent. Variability in patient populations, dosage forms, and dosages complicates the formulation of definitive clinical recommendations. Overall, perioperative nicotine shows promise for improving postoperative pain management, but its impact on PONV requires careful consideration. Nicotine administration has been investigated as an analgesic adjunct and as a strategy for preventing PONV. This systematic review aimed to determine the effect of perioperative nicotine administration on postoperative pain and PONV.

## Linked entities

- **Chemicals:** nicotine (PubChem CID 942)

## Full-text entities

- **Diseases:** analgesia (MESH:D000699), and vomiting (MESH:D014839), opioid misuse (MESH:D009293), stroke (MESH:D020521), bleeding (MESH:D006470), Nausea (MESH:D009325), Postoperative Pain (MESH:D010149), Pain (MESH:D010146), headache (MESH:D006261), PONV (MESH:D020250), renal injury (MESH:D007674), myocardial infarction (MESH:D009203)
- **Chemicals:** dolasetron (MESH:C060344), norepinephrine (MESH:D009638), ketorolac (MESH:D020910), granisetron (MESH:D017829), paracetamol (MESH:D000082), oxygen (MESH:D010100), ondansetron (MESH:D017294), morphine (MESH:D009020), dopamine (MESH:D004298), metoclopramide (MESH:D008787), Nicotine (MESH:D009538), dexamethasone (MESH:D003907), Bitartrate (-)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915354/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915354/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915354/full.md

---
Source: https://tomesphere.com/paper/PMC12915354